Ostro | Axios exclusive: RxDefine, now Ostro, raises $45M for health engagement

November 30, 2022

Axios exclusive: RxDefine, now Ostro, raises $45M for health engagement

Location

Erin Brodwin

Ostro, recently rebranded from RxDefine, is getting an e-commerce makeover and $45 million in Series B funding, CEO Chase Feiger tells Axios exclusively....

Axios exclusive: RxDefine, now Ostro, raises $45M for health engagement

Erin Brodwin

Read more >>

Future Pharma

Previous post

Next post

PanAgora Pharma CX Rare Disease Summit

Previous post

Next post

Pharma's Two Biggest Mistakes

Previous post

Next post

How this CEO Built a Top 50 Pharma Company Focusing on Culture Day 1

Previous post

Next post

A Decade of Innovation: How this CEO Transformed a Global Pharma Giant

Previous post

Next post

How This CEO Consumerized Cancer Diagnostics Into A $13B Enterprise

Previous post

Next post

40 Under 40: Dr. Chase Feiger, Ostro

Previous post

Next post

MM+M announces 2024’s 40 Under 40 honorees

Previous post

Next post

Bringing Generative AI to Healthcare

Previous post

Next post

Brand.com 2.0: A Call to Action for Life Sciences Brands

Previous post

Next post

Elevating health literacy: A win-win for consumers and life sciences companies

Previous post

Next post

This Time It’s Personal—The Key to Improving HCP Engagements

Previous post

Next post

CooperSurgical® and Ostro Named Best Patient Education Solution in the 7th Annual MedTech Breakthrough Awards

Previous post

Next post

3 ways to make sure TV and print ads are driving next-best actions

Previous post

Next post

The key elements to a successful and sustainable patient engagement strategy

Previous post

Next post

The evolving patient journey

Previous post

Next post

Ostro grows annual revenue by over 250%, closes Series B funding, celebrates co-founder

Previous post

Next post

CooperSurgical® partners with Ostro to educate consumers about Paragard® (intrauterine copper contraceptive)

Previous post

Next post

InnovationRx: Under 30 innovators, avoiding Covid brain fog and facing a tripledemic

Previous post

Next post

Axios exclusive: RxDefine, now Ostro, raises $45M for health engagement

Previous post

Next post

Ahmed Elsayyad named 30 under 30 by Forbes

Previous post

Next post

RxDefine is now Ostro

Previous post

Next post

3 HCP hurdles and how marketing can overcome them

Previous post

Next post

4 reasons 1:1 engagement can help you stay ahead of the competition

Previous post

Next post

5 questions to ask about whether telehealth is right for your life sciences brand

Previous post

Next post

5 things life sciences brands should look for when choosing a telehealth provider

Previous post